Dopamine Beta-Hydroxylase Deficiency
Dopamine beta-hydroxylase deficiency is an ultra-rare autonomic disorder caused by the inability to produce norepinephrine, resulting in severe blood pressure dysregulation and exercise intolerance.
Overview
Dopamine beta-hydroxylase deficiency is a rare genetic disorder of the autonomic nervous system, the regulatory network responsible for managing involuntary bodily functions, including core body temperature and blood pressure. The clinical features stem from a profound deficiency of norepinephrine, a vital chemical messenger (neurotransmitter) that transmits signals across the autonomic nervous system.
Signs and Symptoms
Although underlying physiological signs can be present during infancy, many individuals are not formally diagnosed until adolescence, when clinical manifestations often become more pronounced.
Infancy and Early Childhood
- Drooping eyelids (ptosis)
- Consistently low blood pressure (hypotension)
- Recurrent episodes of vomiting and dehydration
- Decreased body temperature (hypothermia)
- Low blood glucose levels (hypoglycemia), frequently resulting in hospitalizations
Adolescence and Adulthood
- Severe drop in blood pressure upon standing (orthostatic hypotension), which can trigger dizziness, blurred vision, or fainting (syncope)
- Pronounced exercise intolerance due to the inability to maintain hemodynamic stability
- Persistent nasal congestion
- Inability to stand upright for extended periods
- Retrograde ejaculation, where semen travels backward into the bladder during ejaculation
Without intervention, symptoms typically escalate during adolescence; however, clinical features may improve substantially with appropriate medical therapy.
Causes and Genetics
The condition is caused by variants (mutations) in the DBH gene. The DBH gene encodes the enzyme dopamine beta-hydroxylase, which is responsible for catalyzing the conversion of dopamine into norepinephrine.
Mutations in this gene eliminate or drastically disrupt the function of the dopamine beta-hydroxylase enzyme. As a consequence, dopamine cannot be converted into norepinephrine, depriving the autonomic nervous system of the neurotransmitter necessary to adjust vascular tone, sustain blood pressure, and maintain proper autonomic function.
Inheritance
Dopamine beta-hydroxylase deficiency follows an autosomal recessive inheritance pattern. An individual must inherit two altered copies of the DBH gene (one from each parent) to develop the condition. Parents of an affected child typically carry one altered copy as asymptomatic carriers, experiencing no signs or symptoms of the disorder themselves.
Prevalence
This condition is exceptionally rare. As of 2021, approximately 25 individuals with dopamine beta-hydroxylase deficiency have been documented in scientific and clinical literature.
Alternative Names
- DBH deficiency
- Dopamine β-hydroxylase deficiency
- Orthostatic hypotension 1
